• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Aastrom Biosciences Inc

Sorin’s 2011 sales stay flat, profits soar | Earnings Roundup

March 16, 2012 By MassDevice staff Leave a Comment

Sorin Group

Sorin Group (BIT:SRN) reported flat sales but strong profit growth for 2011, saying it raised earnings by 48.3% and revealing that the cardiac rhythm management slump has made its way across the pond.

The Italian medical device maker posted net income of €58.0 million (~$75.2 million) on sales of €743.4 million (~$963.4 million) for the year ended Dec. 31, 2011. That compares with profits of €39.1 million (~$50.7 million) on sales of €745.8 million (~$966.5 million) during 2010.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Aastrom Biosciences Inc, American Shared Hospital Services, Atrion, BioMimetic Therapeutics Inc., Draeger Medical, InVivo Therapeutics, Q4, SANUWAVE Health Inc., Sorin Group, Synergetics USA Inc., Utah Medical, Zynex Inc.

VCs press Senate on “IPO On Ramp” bill | Wall Street Beat

March 12, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.

The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.

Filed Under: News Well, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Abbott, Allezoe Medical Holdings, Angel Investment, Angel Resource Institute, Athersys Inc., Atrium Medical Corp., Authentidate, avitamedical, Boston Scientific, C.R. Bard, CareFusion Corp., CB Insights, CJPS Healthcare Supplies & Equipment, Dexcom, Edwards Lifesciences, Flextronics, GE Healthcare, Halt Medical, iCad Inc., Intuitive Surgical, Johnson and Johnson, LensAR Inc., Mobi LLC, National Venture Capital Assn., Nihon Kohden, Nobel Biocare Holdings AG, Nuvasive, Philips, Premier Inc., Silicon Valley Bank, Smith & Nephew, Standard & Poor's, Stellar Microelectronics, Thoratec Corp., U.S. Army, U.S. House of Representatives, U.S. Senate, Venture Capital/Private Equity, Volcano Corp., Welch Allyn

Geron’s exit from stem cell business means opportunity for InVivo, others

November 16, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Amgen, Boston Scientific, Geron Corp., Imaging Diagnostic Systems, Intuitive Surgical, InVivo Therapeutics, INVO Bioscience, Pluristem, StemCells Inc., Steris Corp., Tengion Inc., The Cooper Cos., ThermoGenesis Corp.

Aastrom, Hanger announce public offerings

December 11, 2010 By MassDevice staff Leave a Comment

Aastrom, Hanger logos

More shares from Aastrom Biosciences Inc. (NSDQ:ASTM) and Hanger Orthopedic Group Inc. (NYSE:HGR) are set to hit the market.

Aastrom yesterday priced an offering of 10 million shares at $2.25 a piece on the NASDAQ stock exchange.

Filed Under: Business/Financial News, News Well, Orthopedics, Stem Cells Tagged With: Aastrom Biosciences Inc, Hanger Inc.

Aastrom Biosciences winds up treatment stage of Phase 2 clinical trial

March 9, 2010 By MedCity News Leave a Comment

By Brandon Glenn

Aastrom Biosciences Inc. (NSDQ:ASTMD) finished treating patients in a Phase 2 clinical trial of its cardiac-repair stem cells.

The milestone clears the way for Aastrom to report six-month interim results of the trial later this year, according to a press release.

In the trial, Aastrom treated 40 patients suffering from dilated cardiomyopathy, a severe form of congestive heart failure in which the heart becomes weakened and enlarged and cannot pump blood efficiently.

Filed Under: Business/Financial News, News Well, Stem Cells Tagged With: Aastrom Biosciences Inc, Harvest Technologies Corp.

Aastrom Biosciences back in NASDAQ’s good graces

March 5, 2010 By MedCity News Leave a Comment

By Brandon Glenn

MedCity News logo

ANN ARBOR, Mich. – Aastrom Biosciences (NSDQ:ASTMD), once in danger of being de-listed from the NASDAQ exchange, regained compliance with the exchange’s $1 minimum-share-price requirement.

Filed Under: Business/Financial News, News Well, Stem Cells Tagged With: Aastrom Biosciences Inc

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS